Bell Bank Viatris Inc Transaction History

Bell Bank

$1.18 Billion
Q2 2024

A detailed history of Bell Bank transactions in Viatris Inc stock. As of the latest transaction made, Bell Bank holds 485,119 shares of VTRS stock, worth $5.47 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares

485,119

Previous 488,774 0.75%

Holding current value

$5.47 Million

Previous $5.84 Million 11.64%

% of portfolio

0.44%

Previous 0.51%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	SELL	$10.05 - $12.02 $36,732 - $43,933	-3,655 Reduced 0.75%	485,119 $5.16 Million
Q1 2024 Apr 23, 2024	SELL	$11.27 - $13.53 $75,880 - $91,097	-6,733 Reduced 1.36%	488,774 $5.84 Million
Q4 2023 Jan 22, 2024	SELL	$8.77 - $10.85 $70,800 - $87,592	-8,073 Reduced 1.6%	495,507 $5.37 Million
Q3 2023 Oct 30, 2023	SELL	$9.59 - $11.35 $76,202 - $90,187	-7,946 Reduced 1.55%	503,580 $4.97 Million
Q2 2023 Jul 26, 2023	SELL	$9.02 - $10.29 $235,845 - $269,052	-26,147 Reduced 4.86%	511,526 $5.11 Million
Q1 2023 Apr 19, 2023	SELL	$9.2 - $12.26 $147,678 - $196,797	-16,052 Reduced 2.9%	537,673 $5.17 Million
Q4 2022 Jan 31, 2023	SELL	$8.72 - $11.56 $100,995 - $133,887	-11,582 Reduced 2.05%	553,725 $6.16 Million
Q3 2022 Oct 11, 2022	BUY	$8.48 - $11.13 $545,416 - $715,859	64,318 Added 12.84%	565,307 $4.82 Million
Q2 2022 Jul 15, 2022	BUY	$9.95 - $12.27 $27,034 - $33,337	2,717 Added 0.55%	500,989 $5.25 Million
Q1 2022 Apr 25, 2022	BUY	$9.81 - $15.4 $3.68 Million - $5.78 Million	375,318 Added 305.25%	498,272 $5.42 Million
Q4 2021 Feb 01, 2022	BUY	$12.09 - $14.68 $1.49 Million - $1.8 Million	122,954 New	122,954 $1.66 Million

Others Institutions Holding VTRS

# of Institutions

1,099

Shares Held

969M

Call Options Held

2.63M

Put Options Held

2.15M

View Full List

About Viatris Inc

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $13.7B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

More about VTRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bell Bank, based on Form 13F filings with the SEC.

News

Stay updated on Bell Bank with notifications on news.

Account